503B Outsourcing Facilities — Bacteriostatic Water Supplier Documentation Requirements

503B outsourcing facilities operate under direct FDA oversight under Section 503B of the Drug Quality and Security Act (DQSA). Unlike 503A compounding pharmacies, 503B facilities are registered with the FDA and held to standards that approach those of commercial pharmaceutical manufacturers. Ingredient sourcing — including bacteriostatic water — must meet corresponding documentation requirements.

503A vs 503B: Key Differences for Ingredient Sourcing

Factor	503A Pharmacy	503B Outsourcing Facility
Regulatory Oversight	State Board of Pharmacy	FDA + State Board
Applicable Standards	USP <797>	USP <797> + cGMP
Ingredient Documentation	COA required	COA + supplier qualification required
Patient Prescriptions	Required for most	Not required (anticipatory compounding)

What 503B Facilities Need From BAC Water Suppliers

For 503B facilities, bacteriostatic water documentation requirements include: lot-specific COA with full analytical data, manufacturer quality system documentation (GMP compliance evidence), stability data, and in many cases a supplier qualification questionnaire or audit. Renew Lab Group can provide all standard documentation needed for supplier qualification. Contact us to discuss your facility’s specific requirements.

Consistency and Reliability for High-Volume Operations

503B facilities often require large, consistent volumes of bacteriostatic water for high-throughput compounding operations. Our bulk ordering program is designed for exactly this use case — consistent lot quality, complete documentation, and reliable delivery on schedule.

Related: Pharmacy Wholesale Account | Bulk Ordering | Contact for 503B Accounts